DEVELOPMENT OF ANXIETY-DEPRESSIVE DISORDERS IN GASTROENTEROLOGY
Main Article Content
Abstract
Concomitant depression and anxiety disorders occur in 25% of general practitioners. About 85% of depressed patients have significant anxiety, and 90% of patients with anxiety disorder have depression. Both depressive disorder and specific anxiety disorder require appropriate treatment. Psychological therapies such as cognitive behavioral therapy and antidepressants, sometimes supplemented with antipsychotics, have proven beneficial for treating both depression and anxiety.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Van den Houte K, Colomier E, Schol J, Carbone F, Tack J. Recent advances in diagnosis and management of irritable bowel syndrome. Curr Opin Psychiatry. 2020 Sep;33(5):460-466. doi: 10.1097/YCO.0000000000000628. PMID: 32639360.
Smaardijk VR, Mommersteeg PMC, Kop WJ, Adlam D, Psychological and clinical characteristics of female patients with spontaneous coronary artery dissection. Maas AHEM. Neth Heart J. 2020 Sep;28(9):485-491. doi: 10.1007/s12471-020-01437-7. PMID: 32500434
Koloski N, Holtmann G, Talley NJ. Is there a causal link between psychological disorders and functional gastrointestinal disorders? Expert Rev Gastroenterol Hepatol. 2020 Aug 17:1-13. doi: 10.1080/17474124.2020.1801414. Online ahead of print. PMID: 32715790
Lu J, Shi L, Huang D, Fan W, Li X, Zhu L, Wei J, Fang X. Depression and Structural Factors Are Associated With Symptoms in Patients of Irritable Bowel Syndrome With Diarrhea. JNeurogastroenterol Motil. 2020 Jul 16. doi: 10.5056/jnm19166. Online ahead of print. PMID: 32675388 Free article.
Midenfjord I, Polster A, Sjövall H, Friberg P, Törnblom H, Simrén M. Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms. Sci Rep. 2020 Jun 17;10(1):9794. doi: 10.1038/s41598-020-66558-w. PMID: 32555219 Free PMC article.
Yildiz A, Kizil E, Yildiz A. Quality of life and psychometric evaluation of patients diagnosed with irritable bowel syndrome: an observational cohort study. Sao Paulo Med J. 2020 Jun 15:S1516-31802020005011102. doi: 10.1590/1516-3180.2019.0527.R1.16042020. Online ahead of print. PMID: 32556060 Free article.
Chandan JS, Keerthy D, Zemedikun DT, Okoth K, Gokhale KM, Raza K, Bandyopadhyay S, Taylor J, Nirantharakumar K. E. The association between exposure to childhood maltreatment and the subsequent development of functional somatic and visceral pain syndromes. Clinical Medicine. 2020 Jun 6;23:100392. doi: 10.1016/j.eclinm.2020.100392. eCollection 2020 Jun. PMID: 32637892 Free PMC article.
Friesen C, Singh M, Singh V, Schurman JV. BMC. A cross-sectional study of nausea in functional abdominal pain: relation to mucosal mast cells and psychological functioning. Gastroenterol. 2020 May 11;20(1):144. doi: 10.1186/s12876-020-01291-2. PMID: 32393272 Free PMC article.
Qin G, Zhang Y, Yao SK. Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: Associations with abdominal pain, visceral hypersensitivity and psychological performance.World J Clin Cases. 2020 May 6;8(9):1632-1641. doi: 10.12998/wjcc.v8.i9.1632. PMID: 32432141 Free PMC article.
Shulman RJ, Self MM, Czyzewski DI, Goldberg J, Heitkemper M. The Prevalence of Hypermobility in Children with Irritable Bowel Syndrome and Functional Abdominal Pain Is Similar to that in Healthy Children. J Pediatr. 2020 Jul;222:134-140.e2. doi: 10.1016/j.jpeds.2020.03.033. Epub 2020 May 4. PMID: 32381468
Juza R, Vlcek P, Mezeiova E, Musilek K, Soukup O, Korabecny J. Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders. Med Res Rev. 2020 Sep;40(5):1593-1678. doi: 10.1002/med.21666. Epub 2020 Mar 1. PMID: 32115745 Review.